Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy

European Journal of Haematology

Volumn 68, Issue 4, 2002, Pages 233-235

  Damaj, G ^a,b   Lefrere F ^a   Canioni, D ^a   Rubio, M T ^a   Radford Weiss, I ^a   Valensi, F ^a   Varet, B ^a   Hermine, O ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

Danazol; Myelodysplasia; Myelofibrosis; Remission

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; DANAZOL; GENE PRODUCT; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR;

AGED; ARTICLE; BLOOD SMEAR; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; ECHOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; REMISSION; TRANSFUSION;

AGED; DANAZOL; ESTROGEN ANTAGONISTS; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; MYELOFIBROSIS; REMISSION INDUCTION;

EID: 0036288243     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2002.01669.x     Document Type: Article

References (10)

1. Spontaneous remission in adult acute leukemia
2. Transient spontaneous remission in a case of adult acute myelogenous leukaemia
3. Danazol therapy for autoimmune hemolytic anemia
4. Danazol treatment of idiopathic myelofibrosis with severe anemia
5. Danazol treatment of myelodysplastic syndromes
6. Acute myeloid leukemia
7. A spontaneous remission of lymphoid blast crisis in chronic myelogenous leukaemia following blood transfusion and infection
8. Spontaneous remission in acute myeloid leukaemia
9. Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases
10. Very low dose danazol in idiopathic thrombocytopenic purpura and its role as an immune modulator